Solara Active Pharma Sciences Board Adopts Updated Board Evaluation and Whistle Blower Policies
Solara Active Pharma Sciences Limited announced that its Board of Directors, during a meeting held on May 15, 2026, approved and adopted key revisions concerning corporate governance policies.The company’s board officially adopted the 'Board Evaluation Policy.' This policy was implemented to align with applicable regulations.
Additionally, the existing 'Whistle Blower Policy' underwent amendments, incorporating necessary revisions and modifications to align with current requirements.
The updated Board Evaluation Policy and the revised Whistle Blower Policy are available for review on the Company's official website.
SOLARA Stock Price Movement
Shares of Solara Active Pharma Sciences Limited are surging to ₹582.75 as of 3:15 PM today, gaining 14.78% in live trading. The stock is experiencing significant interest, trading on a total volume of 3.73 million shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.